Tawil E, Mercier J P
Can Med Assoc J. 1984 Jul 15;131(2):115-8.
We retrospectively reviewed 224 cases of Hodgkin's disease, in 120 of which staging laparotomy was performed. The surgical findings in cases of clinical stage I or II disease with supradiaphragmatic presentation or clinical stage III disease did not influence the treatment plans. Of the 64 patients with positive results of laparotomy (splenic or lymph node involvement or both) 51 had splenic involvement; their 5-year survival rate, 57%, was similar to that of the patients with clinical or pathological stage III disease - 58% and 54% respectively. At laparotomy 11 patients with pathological stage III disease were found to have isolated splenic involvement; their 5-year survival rate, 64%, was not appreciably different from that of the patients with clinical stage II disease, 70%; both groups were treated with radiotherapy only. From this study we can conclude that splenic involvement in Hodgkin's disease has no deleterious effect on survival and that splenic irradiation seems to be as effective as splenectomy in controlling the disease.
我们回顾性研究了224例霍奇金病患者,其中120例行分期剖腹探查术。临床Ⅰ期或Ⅱ期伴有膈上表现的疾病或临床Ⅲ期疾病患者的手术发现并未影响治疗方案。在剖腹探查结果阳性(脾或淋巴结受累或两者均受累)的64例患者中,51例有脾受累;他们的5年生存率为57%,与临床或病理Ⅲ期疾病患者的生存率相似,分别为58%和54%。在剖腹探查时,发现11例病理Ⅲ期疾病患者有孤立性脾受累;他们的5年生存率为64%,与临床Ⅱ期疾病患者的生存率70%无明显差异;两组均仅接受放射治疗。从这项研究中我们可以得出结论,霍奇金病中的脾受累对生存没有有害影响,并且脾照射在控制疾病方面似乎与脾切除术一样有效。